Genomic analysis company Genoox has raised $6 million in funding. Inimiti Capital Partners and Glilot Capital Partners led the round. PRESS RELEASE NEW YORK – Today, Genoox, the genomic analysis company on a mission to make it easier and more affordable for doctors, clinicians and researchers to improve patient outcomes using big data, announced a […]

WOBURN, Mass.–SeqLL, LLC announced today that it has been awarded a Phase I SBIR grant in the amount of $223,465 by the NIH/National Human Genome Research Institute to advance the development of Direct RNA Sequencing (DRS™) technology on SeqLL’s True Single Molecule Sequencing (tSMS™) platform. The Phase I grant will allow SeqLL to improve DRS […]

Company completes Series D funding and adds two new directors to board (ANN ARBOR, Mich.) Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the completion of a Series D funding raise of $12.2 million. The company also announced the addition of two new directors to its board, positioning the […]

SANTA BARBARA, Calif. — SerImmune Inc. today announced an $8 million round of financing, led by Illumina Ventures, with participation from Merck, known as MSD outside the United States and Canada, through a subsidiary, and additional undisclosed investors. With the proceeds, SerImmune will expand its immune mapping technology platform and antibody repertoire database while building strategic […]

A New Orleans startup exploring the diagnostic aspects of genetic research has received more than $1 million from investors and plans to expand its business. Pine Biotech, based at the New Orleans BioInnovation Center on Canal Street, has developed a software program to help scientists analyze and map large sets of molecular data — also […]

Research in space will use Emulate’s Organs-on-Chips technology to evaluate effects of space travel on human brain cells, and may help uncover new insights to understand neurological diseases on Earth $2 million grant provided by NCATS, a center of the NIH; logistical support provided by CASIS, managers of the International Space Station U.S. National Laboratory […]

MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (NASDAQ:PACB) (the “Company”) today announced that it has priced its previously announced underwritten public offering of 15,419,354 shares of its common stock at a price to the public of $3.10 per share.  The offering is expected to close on or about June 20, 2017 subject to […]

— Aggregate New Funding in 2017 Reaches $60 Million; Total of $191 Million Raised Since Inception – — Accelerates Growth into Drug Discovery, Supports Investment in DNA Data Storage – SAN FRANCISCO, Calif. – Twist Bioscience Corporation, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced that it raised an additional […]

Company’s strong growth and technical expertise in managing clinical trials attracts growth equity investment SEATTLE—-LabConnect, a leading provider of highly customized global central laboratory and support services to biopharmaceutical, medical device, and contract research organizations (CROs), announced today a $24.5 million Series A investment by ABS Capital Partners, a leading late-stage growth company investor, Pablo […]

SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 3,450,000 shares of its common stock at a price of $16.75 per share, which includes the exercise in full by the underwriter of its option to purchase an […]